Rationale and design of a screening study to detect schistosomiasis‐associated pulmonary hypertension in Ethiopia and Zambia
Sign Up to like & getrecommendations! Published in 2022 at "Pulmonary Circulation"
DOI: 10.1002/pul2.12072
Abstract: Abstract Schistosomiasis is a major cause of pulmonary arterial hypertension (PAH) worldwide, but the prevalence and risk factors for schistosomiasis‐associated PAH (SchPAH) development are not well understood. Schistosomiasis‐associated hepatosplenic disease (SchHSD) is thought to be… read more here.
Keywords: screening study; hypertension; schistosomiasis associated; schistosomiasis ... See more keywords
Effect of targeted therapies on survival of schistosomiasis associated pulmonary arterial hypertension
Sign Up to like & getrecommendations! Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.pa3524
Abstract: Schistosomiasis associated pulmonary arterial hypertension (Sch-PAH) is one of the most prevalent forms of pulmonary hypertension, mainly in developing countries. Although Sch-PAH seems to have a more benign clinical course than idiopathic pulmonary arterial hypertension,… read more here.
Keywords: arterial hypertension; schistosomiasis associated; pulmonary arterial; sch pah ... See more keywords
MULT1-Encoding DNA Alleviates Schistosomiasis-Associated Hepatic Fibrosis via Modulating Cellular Immune Response
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Inflammation Research"
DOI: 10.2147/jir.s354224
Abstract: Purpose In schistosomiasis-associated hepatic fibrosis, the role of murine UL16-binding protein-like transcript 1 (MULT1), the strongest ligand of natural killer group 2-member D receptor (NKG2D), remains unclear. Here, Schistosoma japonicum-infected mice administered with MULT1-encoding DNA… read more here.
Keywords: hepatic fibrosis; schistosomiasis associated; group; associated hepatic ... See more keywords